ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 2039 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 2039; 2) Community: the network communities that were significantly associated with the response to NSC 2039; 3) Molecule: the relationships between components within communities and NSC 2039; 4) MDR: the compounds that were significantly associated with the NSC 2039.

NSC Compound Enrichment Correlation
NSC 73735 B 3845 0.0186186224062459 0.39752197
NSC 743396 Null 0.0186186224062459 0.27323041
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.0186186224062459 0.24703923
NSC 750324 Null 0.0186186224062459 0.11902114
NSC 752365 2-[6-(4-Hydroxy-3-methoxy-benzylamino)-hexyl]-benzo[de]isoquinoline-1,3-dione para toluen sulphonate 0.0186186224062459 0.45269718
NSC 88915 Null 0.0186186224062459 0.38088124
NSC 271674 Carboxyphthalatoplatinum 0.0212053315848709 0.39674618
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.0212053315848709 0.33237472
NSC 376266 1-Piperazinethiocarboxylic acid, 4-(2-propynyl)- 2-[1-(2-pyridinyl)ethylidene]hydrazide 0.0212053315848709 0.42005502
NSC 646604 Null 0.0212053315848709 0.31177639
Total:80  Current:41    [First] [Prev] [Next] [Last]